BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 91 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $93,000 | +78.8% | 27,465 | +54.8% | 0.00% | – |
| Q4 2018 | $52,000 | -67.1% | 17,744 | -16.8% | 0.00% | – |
| Q2 2018 | $158,000 | +49.1% | 21,334 | +32.1% | 0.00% | – |
| Q1 2018 | $106,000 | -8.6% | 16,145 | +17.4% | 0.00% | – |
| Q4 2017 | $116,000 | -56.1% | 13,753 | -39.8% | 0.00% | – |
| Q3 2017 | $264,000 | +76.0% | 22,850 | +88.1% | 0.00% | – |
| Q1 2017 | $150,000 | -71.0% | 12,146 | -68.0% | 0.00% | -100.0% |
| Q4 2016 | $518,000 | -4.1% | 38,013 | +40.0% | 0.00% | 0.0% |
| Q3 2016 | $540,000 | +17.4% | 27,158 | -23.5% | 0.00% | 0.0% |
| Q2 2016 | $460,000 | +58.1% | 35,484 | +13.7% | 0.00% | – |
| Q1 2016 | $291,000 | -33.4% | 31,199 | +44.8% | 0.00% | -100.0% |
| Q4 2015 | $437,000 | – | 21,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |